Sentences with phrase «share growth rates»

Starting on December 31, 1954 (we need five years of data to compute the compound five - year earnings growth rate), $ 10,000 invested in the 50 stocks from the All Stocks universe with the highest five - year compound earnings - per - share growth rates grew to $ 1,287,685 by the end of 2003, a compound return of 10.42 percent (Table 12 - 1).

Stocks are screened by defined historical non-negative dividend - per - share growth rates and dividend to earnings - per - share ratios.

Share statistics for ADR companies — including price - earnings ratios, earnings per share growth rates, and shares outstanding — may be difficult to interpret unless you understand the per share conversion ratio and the inconsistent reporting of quarterly financial statements.

Some of these factors include above - average earnings per - share growth rates, above - average return on equity, excess - free cash flow, low debt - to - equity ratios, and shareholder - friendly management.

Some of these factors include above average earnings per - share growth rates, above average return on equity, excess free cash flow, low debt - to - equity ratios, and shareholder friendly management.

Currently, the company is trading at about 25 times earnings and with a long - term earnings per share growth rate of about 15 %, its price - to - earnings to growth ratio — a metric used to value fast growing companies — is about 1.4.

The key number here is the PEG ratio — a company's forward four - quarter price - to - earnings ratio plus its future annual earnings - per - share growth rate.

Philip Morris is expecting an 8 % to 10 % currency neutral earnings - per - share growth rate in 2010, around the same growth rate the company has experienced over the last several years.

This indicates a relatively solid earnings per share growth rate of 184.23 % over the next few years, which is an optimistic outlook in the near term.

Altria's 7 % to 9 % target earnings - per - share growth rate combined with its 4 % + dividend yield gives investors expected total returns of 11 % to 13 % a year.

Its average three - year earnings - per - share growth rate comes in at 32.4 % and revenue - per - share growth clocks in at an average of 13.9 % over the same period.

That means that going forward Hormel's dividend growth is likely to closely match its EPS and FCF per share growth rate.

To weed out those at risk of cutting their dividend, companies must have a positive five - year dividend - per - share growth rate and a dividend payout ratio of no more than 60 % of earnings.

My addition to the Tweedy Browne commentary is that I believe investors should focus on the earnings per share growth rate of the firm during your holding period to figure out whether it makes sense.

Intel's seven - year earnings per share growth rate of 1.4 % is the lowest of the passing stocks.

Used to provide a confirmation of the quality of the historical earnings per share growth rate.

It allows you to search for companies using a wide range of criteria such as earnings per share, net income growth and even earnings per share growth rate.

Book - value - per - share growth rate is used in place of revenue - per - share growth for some financial stocks.

It sports the highest average three - year earnings - per - share growth rate at 77 % and has a modest book value multiple of 0.9.

In addition to J M Smucker's expected earnings - per - share growth rate of 8 %, the company also has a dividend yield of 2.4 %.

At first, that doesn't sound all that different from Hershey, until you adjust for the fact that the future earnings per share growth rate of Visa is much higher than what you can get from Hershey.

In order to pass either screen, a company must rank in the top 25 % of the stock universe based on long - term earnings growth, have a three - year earnings per share growth rate that is equal to or exceeds its seven - year earnings growth rate, and have positive earnings for each of the last seven years.

The PEG ratio is computed by dividing the normalized price - earnings ratio (price divided by the consensus earnings per share estimate for the current fiscal year) by the estimated earnings per share growth rate for the next three to five years.

Not exact matches

I am pleased to announce that our Board of Directors declared a 7 % increase in our quarterly cash dividend to $ 0.77 per share, marking 14 consecutive years of dividend increases with a compound annual growth rate of about 10 % over that period.

«While we agree that share repurchase is likely more accretive to 2018 EPS, [Express Scripts»] more pressing challenge is business growth, making deals like eviCore a necessity,» said RBC's Hill, who has a sector perform rating on Express Scripts shares.

Moreover, the rate of growth in the fraction of non-employers (28.2 percent) run by women has been higher than the rate of increase in their share of non-employers (23 percent) over the past five years.

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

Sanderson thinks that listening hours can expand at a 14 % compound annual growth rate through 2017 and 11 % through 2020, while its share of people who listen to music can grow from 8 % in 2013 to 18 % by 2020.

Both startup growth rate and share of scaleups are employment - based measurements, and share of scaleups refers to companies that grew to 50 employees or more in less than 10 years of operation.

To rank the cities, the researchers took three factors into account: startup growth rate, share of scaleups and high - growth company density.

That rate helped push it to a 32 percent share of the top 12 selling large luxury sedans, and «significantly outpaced» the U.S. large luxury sedan category's sales growth, it said.

J.P. Morgan initiates coverage for Spotify shares with an overweight rating, predicting strong user growth over the next five years.

J.P. Morgan reiterates its overweight rating for Caterpillar shares, predicting strong sales growth for its equipment through 2022.

Oakland - based Revolution Foods (# 2) is growing at a 5 - year compounded annual growth rate of 144 %, and is setting a new standard in the food industry by offering profit sharing to its employees.

For the upcoming season, assuming the league maintained its annual rate of 7.1 % growth, the players» 57 % share under the current CBA would net them roughly $ 2 billion.

KeyBanc Capital Markets initiates coverage for Roku shares with an overweight rating, predicting the company will generate strong sales growth this year.

J.P. Morgan initiates coverage of Spotify shares with an overweight rating, predicting strong user growth over the next five years.

J.P. Morgan raises its rating to overweight from neutral for New York Times Company's shares, predicting strong profit growth over the next two years.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Echelon is now focusing its growth on «smart» commercial & municipal LED lighting (although its fab-less chip business has apparently now stabilized after a long decline), and if the lighting business accelerates (and it could, due to recent sales force hires and new products), I think there's a chance it can hit a break - even annualized revenue run - rate of $ 40 million by Q4 - 2019 (pushed back from my earlier hoped - for timeline) at which point — assuming $ 14 million of remaining net cash (vs. an estimated $ 18 million at the end of Q2 2018) and 4.7 million shares outstanding (vs 4.52 million today), an enterprise value of 1x revenue on this 53 % gross margin company would put the stock in the mid - $ 11s per share.

For example, if company ABC and XYZ are both selling for $ 50 a share, one might be far more expensive than the other depending upon the underlying profits and growth rates of each stock.

The U.S. rate hike that the market is 100 percent certain will be delivered this week did not stop Dividend Equity Funds from recording their biggest inflow since the record setting $ 9.4 billion they took in exactly three years ago, with investors translating recent earnings per share growth and expected repatriation of foreign cash piles into bigger dividend payouts.

This growth rate is the compound annual growth rate of cash dividends per common share of stock over the last 5 years.

Although their growth rates have slowed, their share of GDP has continued to increase and the importance of these countries to the pace of global growth has also increased.

This conundrum shares some characteristics and common roots with the theory of secular stagnation; in both scenarios, interest rates, growth, and inflation are persistently low (Summers 2015).

For equity markets, the combination of low interest rates, strong economic growth and low inflation has proved very beneficial, with global share markets rising solidly in each of the past three years.

This is normally accomplished by taking the dividends earned on each share and dividing it by the share's current market value, and then adding the share's dividend growth rate to the equation to equal the rate or return required.

In other words, rather than productivity advances being the cause of higher real wages, the reverse may be true: Higher labor costs that crimp the profits share and boost the labor share are a necessary condition for higher investment rates which in turn will lead to higher productivity growth.

Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, increased competition; the Company's ability to maintain, extend and expand its reputation and brand image; the Company's ability to differentiate its products from other brands; the consolidation of retail customers; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue growth in its key product categories, increase its market share, or add products; an impairment of the carrying value of goodwill or other indefinite - lived intangible assets; volatility in commodity, energy and other input costs; changes in the Company's management team or other key personnel; the Company's inability to realize the anticipated benefits from the Company's cost savings initiatives; changes in relationships with significant customers and suppliers; execution of the Company's international expansion strategy; changes in laws and regulations; legal claims or other regulatory enforcement actions; product recalls or product liability claims; unanticipated business disruptions; failure to successfully integrate the Company; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the nations in which the Company operates; the volatility of capital markets; increased pension, labor and people - related expenses; volatility in the market value of all or a portion of the derivatives that the Company uses; exchange rate fluctuations; disruptions in information technology networks and systems; the Company's inability to protect intellectual property rights; impacts of natural events in the locations in which the Company or its customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; the Company's dividend payments on its Series A Preferred Stock; tax law changes or interpretations; pricing actions; and other factors.

Over the past 30 years, during which earnings growth hasn't been stellar, market values have instead been driven by Federal Reserve - induced low interest rates leading to corporate share repurchase strategies and merger and acquisition activity.